Tesamorelin (Egrifta)
FDA-approved as Egrifta, but only to cut extra belly fat in adults with HIV who have a fat problem called lipodystrophy.
Pending medical review
What is it?
Tesamorelin is a peptide medicine. It acts like the body signal that tells you to make growth hormone. The brand is Egrifta. You need a prescription.
Why do people use it?
Doctors use it to lower extra fat deep in the belly in adults with HIV who have lipodystrophy. Lipodystrophy means body fat moves to the wrong places.
Does it really work?
It is FDA-approved for that one use. The label says it is not for weight loss, because it does not change total weight.
Is it safe? Side effects
- Common side effects on the label include joint pain and redness or itching where the shot goes in.
- The label warns about fluid buildup, higher blood sugar, and allergic reactions.
- It raises a body signal called IGF-1, which doctors check.
Is it legal in the US?
Yes, Egrifta is FDA-approved for its labeled use. (The FDA is the US agency that checks if medicines are safe and work.) Using it for anti-aging or weight loss is not an approved use.
Talk to your doctor
Do not start any peptide on your own. Ask a doctor first. We never share doses or tell you where to buy. Print our doctor questions sheet.
FAQ
What is Tesamorelin (Egrifta)?
Tesamorelin is a peptide medicine. It acts like the body signal that tells you to make growth hormone. The brand is Egrifta. You need a prescription.
Does Tesamorelin (Egrifta) work?
It is FDA-approved for that one use. The label says it is not for weight loss, because it does not change total weight.
Is Tesamorelin (Egrifta) legal in the US?
Yes, Egrifta is FDA-approved for its labeled use. (The FDA is the US agency that checks if medicines are safe and work.) Using it for anti-aging or weight loss is not an approved use.
Related pages
- SermorelinWas approved, now off the market
- CJC-1295Not enough proof
- IpamorelinNot enough proof
- Are Peptides Legal in the US?Guide
- What Peptides Are FDA Approved? (2026 List)Guide
- FDA warning letters trackerTool